Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / fin-48-reserve-update-post-nopa.docx
fin-48-reserve-update-post-nopa.docx
Parties
Harkness LLP
Global Tax Penterra Pharmaceuticals Corp
General Counsel Penterra Pharmaceuticals Corp
Penterra Pharmaceuticals Corp
Associates LLP
Pricing Structure Penterra Pharmaceuticals Corp
Penterra Manufacturing Ireland Ltd
Whitmore Valuation Group LLC
Dates
November 20, 2023
October 12, 2023
November 8, 2023
December 22, 2023
March 15, 2012
July 1, 2012
May 16, 2022
June 2, 2022
June 20, 2022
January 1, 2018
Amounts
$380.4
$62.4
$6.82
$1.47
€2.14
€1.06
$312
$235.01
$188.04
$540
Obligations
Accordingly, the ASC 740-10 analysis for transfer pricing positions must consider the entire range of possible outcomes and their associated probability weightings, rather than evaluating a single all-or-nothing outcome
The issuance of a NOPA is a significant event that must be evaluated in connection with the reporting-date assessment of uncertain tax positions